Clinical trial for Low Vision
Official title Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
ClinicalTrials.gov ID: NCT07577219
What this study is testing
- What it's testing
- The study will see if using both eyes together with visual and sound feedback can improve how well people move their eyes to track and look at objects.
- Who it's for
- It is looking for adults who have lost central vision in both eyes because of macular degeneration.
- What's involved
- Participants will do eye‑tracking exercises in a virtual reality setting, getting real‑time visual and audio cues while they move their eyes. They will have five weekly sessions.
- Time commitment
- The program lasts five weeks, with one training session each week and some follow‑up tests to measure eye‑movement and vision changes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 and older
You may be able to join if
- Bilateral central scotomas confirmed via computerized tangent screen Visual acuity between 20/60 and 20/200 (0.5 - 1.00 logMAR) in either eye Stable...
You likely can't join if
- Unstable ocular disease (e.g., ongoing treatments and/or injections) Peripheral vision loss of less than 40 degrees Conditions affecting oculomotor...
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.